Making Health Care Personal – The Power of You is the first installment in the initiative. It will roll out to leaders June 21 and to all employees beginning June 28 with an invitation from C. Wright Pinson, MBA, MD, Deputy CEO and Chief Health System Officer, that confirms automatic enrollment.
Lymphedema study results could be a game-changer for breast cancer patients and survivors. The Vanderbilt-led trial found that patients with early detection who used L-Dex with additional intervention were less likely to progress to chronic lymphedema than patients monitored with a tape measure receiving the same intervention.
Elizabeth Perkins, MD, assistant professor of Otolaryngology-Head and Neck Surgery, joined the surgical faculty in the Department of Otolaryngology in August 2021, and she is serving as co-director of Pediatric Neurotology at Monroe Carell Jr. Children’s Hospital at Vanderbilt.
Vanderbilt researchers have identified blood-based biomarkers associated with complete responses to neoadjuvant chemotherapy in patients with breast cancer.
Accessibility Tools